The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors

PURPOSE: It remained unclear whether tyrosine kinase inhibitors (TKIs) related renal impairment had impact on the survival of patients with metastatic renal cell carcinoma (mRCC). METHODS: Clinicopathological parameters of patients with mRCC treated with TKIs were retrospectively reviewed. Blood ure...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haoran, Zhang, Xingming, Zhu, Xudong, Ni, Yuchao, Dai, Jindong, Zhu, Sha, Sun, Guangxi, Wang, Zhipeng, Chen, Junru, Zhao, Jinge, Zeng, Hao, Li, Zi, Shen, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480366/
https://www.ncbi.nlm.nih.gov/pubmed/33269597
http://dx.doi.org/10.1177/1073274820977143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480366/
https://www.ncbi.nlm.nih.gov/pubmed/33269597
http://dx.doi.org/10.1177/1073274820977143

Ejemplares similares